Related Experiment Videos
Increased platelet monoamine oxidase activity in affective disorders
Psychopharmacology
|January 1, 1981
Summary
Platelet monoamine oxidase (MAO) activity was higher in unipolar and bipolar depressive patients compared to controls. Women exhibited higher MAO activity than men, irrespective of diagnosis or treatment.
Area of Science:
- Neuroscience
- Biochemistry
- Psychiatry
Background:
- Platelet monoamine oxidase (MAO) is an enzyme involved in neurotransmitter metabolism.
- Altered MAO activity has been implicated in various mood disorders.
- Understanding MAO activity in depression is crucial for neurobiological insights.
Purpose of the Study:
- To investigate platelet monoamine oxidase (MAO) activity in patients with unipolar and bipolar affective disorders.
- To compare MAO activity between genders and in relation to age and lithium treatment.
- To explore potential biomarkers for affective disorders.
Main Methods:
- Platelet MAO activity was measured using phenylethylamine as a substrate.
- Enzyme activity was determined in 52 unipolar depressive patients, 26 bipolar affective disorder patients, and 48 healthy controls.
- Correlations with age, serum lithium levels, and changes after lithium treatment were analyzed.
Main Results:
- Unipolar depressive patients and bipolar depressive women demonstrated significantly elevated platelet MAO activity compared to controls.
- Female participants exhibited higher MAO activity than male participants.
- No significant correlation was found between MAO activity and age or serum lithium levels. Lithium treatment did not alter enzyme activity.
Conclusions:
- Elevated platelet MAO activity is associated with unipolar depression and bipolar depression in women.
- Gender differences in MAO activity may play a role in affective disorders.
- Platelet MAO activity is not influenced by age or lithium treatment in these patient groups.